Tasso Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 18

Tasso General Information

Description

Developer of minimally invasive blood collection devices designed to enable convenient, needle-free sample collection for clinical and research applications. The company's devices collect whole blood samples without traditional phlebotomy and support decentralized clinical trials, longitudinal sampling, and remote patient testing, enabling healthcare and life sciences organizations to improve patient engagement, expand access to diverse populations, and simplify blood sample collection and logistics.

Contact Information

Website
www.tassoinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 2nd Avenue West
  • 3rd Floor
  • Seattle, WA 98119
  • United States
+1 (206)
Primary Industry
Medical Supplies
Other Industries
Diagnostic Equipment
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 400 2nd Avenue West
  • 3rd Floor
  • Seattle, WA 98119
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tasso Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 01-Jun-2025 Completed Generating Revenue
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC (Series B) 23-Nov-2021 Completed Generating Revenue
10. Later Stage VC (Series A) 22-Jul-2020 Completed Generating Revenue
9. Seed Round 05-Mar-2019 Completed Generating Revenue
8. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
7. Grant 21-Sep-2017 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
5. Grant 01-Jan-2016 $220K $1.5K Completed Generating Revenue
4. Grant 01-Jan-2015 $3.99M $1.5K Completed Generating Revenue
To view Tasso’s complete valuation and funding history, request access »

Tasso Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-2
Series B-1
Series A 9,557,528 $0.000100 6% $1.78 $1.78 1x $1.78 13.99%
Seed 6,339,672 $0.000100 6% $0.98 $0.98 1x $0.98 9.28%
To view Tasso’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Tasso Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of minimally invasive blood collection devices designed to enable convenient, needle-free sample collection fo
Medical Supplies
Seattle, WA
100 As of 2026

Gland, Switzerland
 

Union City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tasso Competitors (11)

One of Tasso’s 11 competitors is HemaXis, a Venture Capital-Backed company based in Gland, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemaXis Venture Capital-Backed Gland, Switzerland
Abaxis Formerly VC-backed Union City, CA
Vortex Biosciences Venture Capital-Backed Manchester, United Kingdom
Spot On Sciences Private Equity-Backed San Francisco, CA
Nucleix Venture Capital-Backed Rehovot, Israel
You’re viewing 5 of 11 competitors. Get the full list »

Tasso Patents

  • 116

    Total Documents Applications and Grants

  • Total Patents Families

  • 67

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

Tasso Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260305994-A1 High-volume bodily fluid collection devices and related systems and methods Pending 04-Apr-2025
WO-2026213627-A1 High-volume bodily fluid collection devices and related systems and methods Pending 04-Apr-2025
WO-2026064641-A1 Bodily fluid collection tube devices and associated methods and systems Pending 20-Sep-2024
WO-2026064426-A1 Methods and systems for collecting bodily fluid Pending 17-Sep-2024
US-20260076598-A1 Methods, systems, and apparatuses for collecting a high volume of bodily fluid using handheld bodily fluid collection devices Pending 17-Sep-2024 A61B5/150267
To view Tasso’s complete patent history, request access »

Tasso Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tasso Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altered Capital Venture Capital Minority
Global Health Innovation Corporation Minority
InCube Ventures Corporate Venture Capital Minority
OMX Ventures Venture Capital Minority
RA Capital Management Asset Manager Minority
You’re viewing 5 of 18 investors. Get the full list »

Tasso Investments (1)

Tasso’s most recent deal was a Joint Venture with Tasso-SNBL. The deal was made on 27-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tasso-SNBL 27-Mar-2025 Joint Venture Distributors/Wholesale
To view Tasso’s complete investments history, request access »

Ready to get started?

Request a free trial

Tasso FAQs

  • When was Tasso founded?

    Tasso was founded in 2012.

  • Where is Tasso headquartered?

    Tasso is headquartered in Seattle, WA.

  • What is the size of Tasso?

    Tasso has 100 total employees.

  • What industry is Tasso in?

    Tasso’s primary industry is Medical Supplies.

  • Is Tasso a private or public company?

    Tasso is a Private company.

  • What is Tasso’s current revenue?

    The current revenue for Tasso is .

  • How much funding has Tasso raised over time?

    Tasso has raised $123M.

  • Who are Tasso’s investors?

    Altered Capital, Global Health Innovation, InCube Ventures, OMX Ventures, and RA Capital Management are 5 of 18 investors who have invested in Tasso.

  • Who are Tasso’s competitors?

    HemaXis, Abaxis, Vortex Biosciences, Spot On Sciences, and Nucleix are some of the 11 competitors of Tasso.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process